Narek Shaverdian

15PUBLICATIONS
94CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapyMolecular targetsHealth promotion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 07, 2026
Canakinumab with chemoradiation and durvalumab consolidation in unresectable stage III non-small cell lung cancer: the phase I/II CHORUS trial.

|Jul 16, 2026
Durvalumab With Radiation Therapy in Patients With Inoperable Locally Advanced Non-Small Cell Lung Cancer Ineligible for Concurrent Chemoradiotherapy (DART).

|May 14, 2026
Multimodal Impact of Number of Metastases and Genetic Alterations on Survival in Metastatic Non-Small Cell Lung Cancer.

|Sep 09, 2025
Real-world outcomes of neoadjuvant chemoimmunotherapy in patients with nonsmall cell lung cancer: Predictors of surgery, pathologic complete response, and event-free survival.

Alissa J Cooper, Edoardo Garbo, Andrea Arfe

|Aug 29, 2025
Phase I Dose-Escalation Trial Combining Olaparib and Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer.

Andreas Rimner, Benjamin H Lok, Daphna Y Gelblum

|Oct 01, 2024
Real-world Decision-making Process for Stereotactic Body Radiotherapy Versus Minimally Invasive Surgery in Early-stage Lung Cancer Patients.

Stijn Vanstraelen, Kay See Tan, Prasad S Adusumilli

Pageof 3

Frequent Collaborators

5 joint publications

Andreas Rimner

5 joint publications

Abraham J Wu

4 joint publications

Daniel R Gomez

4 joint publications

Charles B Simone